Myocardial Iron Deficiency in Hemodialysis-Dependent End-Stage Renal Disease Patients Undergoing Oral Iron Therapy

• Published in: Journal of the American College of Cardiology Vol. 70; no. 19; pp. 2455 - 2456
• Main Authors: Xu, Hua-yan, Yang, Zhi-gang, Li, Rui, Shi, Ke, Zhang, Yi, Li, Zhen-lin, Xia, Chun-chao, Peng, Wan-lin, Chen, Qing-yong, Guo, Ying-kun
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 07.11.2017; Elsevier Limited
• Subjects: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Anemia, Iron-Deficiency - etiology; Anemia, Iron-Deficiency - metabolism; Cardiology; Cardiovascular; End-stage renal disease; Female; Hemodialysis; Humans; Iron; Iron - metabolism; Iron deficiency; Kidney diseases; Kidney Failure, Chronic - complications; Kidney Failure, Chronic - metabolism; Kidney Failure, Chronic - therapy; Kidney transplantation; Liver; Male; Middle Aged; Myocardium - metabolism; Nutrient deficiency; Renal Dialysis; Young Adult; Canada; Calgary Alberta Canada; Alberta Canada; Germany

Iron deficiency is the most common complication and the main cause of anemia in patients with hemodialysis-dependent end-stage renal disease (ESRD). [...]there is evidence indicating that SF and liver iron are poor indicators for tissue iron in some vital organs such as the heart (3). [...]quantitat...